May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Effect of Anti-Glaucoma Drugs on Inflammatory Cytokine Production by Human and Murine Peripheral Blood Mononuclear Cells
Author Affiliations & Notes
  • K. Kawai
    Ophthalmology, Tokai Univ School of Medicine, Isehara, Japan
  • H. Oohashi
    Ophthalmology, Tokai Univ School of Medicine, Isehara, Japan
  • T. Suzuki
    Ophthalmology, Tokai Univ School of Medicine, Isehara, Japan
  • Footnotes
    Commercial Relationships  K. Kawai, None; H. Oohashi, None; T. Suzuki, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3815. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Kawai, H. Oohashi, T. Suzuki; Effect of Anti-Glaucoma Drugs on Inflammatory Cytokine Production by Human and Murine Peripheral Blood Mononuclear Cells. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3815. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We previously reported that suppression of inflammation after surgery leads to suppression of postoperative elevation of intraocular pressure. We investigated human and murine peripheral blood mononuclear cells to find a drug that suppresses inflammation from among the anti-glaucoma drugs used to lower intraocular pressure.

Methods: : Peripheral blood mononuclear cells (PBMCs) prepared from healthy males and BALB/C mice were suspended in RPMI 1640 culture medium containing 10% FBS, each test drug (beta-antagonists ; timolol, betaxolol, levobunolol, nipradilol,carteolol carbonic anhydrase inhibitor (CAI) ; dorzolamide prostaglandin (PG) ; isopropyl unoprostone, latanoprost ) was added, and they were cultured in a CO2 incubator (set to 37°C and 5% CO2) for 30 minutes. Then, lipopolysaccharide (LPS) was added and they were cultured for a given period of time, after which TNF-alpha or IL-6 levels in the culture medium were determined by ELISA.

Results: : The beta-stimulant salbutamol inhibited production of TNF-alpha, which is an inflammatory cytokine that comes from human and murine PBMCs. Carteolol, which has an intrinsic sympathomimetic action (ISA), inhibited production of TNF-alpha or IL-6 from PBMCs in a dose-dependent manner. On the other hand, an inhibitory action was not observed in the case of timolol, betaxolol, levobunolol, and nipradilol, which are beta-antagonists with no intrinsic sympathomimetic action. Dorzolamide, isopropyl unoprostone and latanoprost had almost no effect on production of inflammatory cytokines.

Conclusions: : It was demonstrated that carteolol exhibited an inhibitory action on production of inflammatory cytokines from PBMCs because of its intrinsic sympathomimetic action. Moreover, it was shown that CAI and PG drugs had almost no effect on inflammatory cytokine production.

Keywords: receptors: pharmacology/physiology • inflammation • carbonic anhydrase 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×